Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abdelmaroof Suliman"'
Autor:
Abdelrahim O. Mohamed, Maazza Hussien, Amal Mohamed, Abdelmaroof Suliman, Nuha S. Elkando, Hanadi Abdelbagi, Elfatih M. Malik, Mohammed H. Abdelraheem, Muzamil Mahdi Abdel Hamid
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-7 (2020)
Abstract Background Plasmodium falciparum malaria is a public health problem worldwide. Malaria treatment policy has faced periodic changes due to emergence of drug resistant parasites. In Sudan chloroquine has been replaced by artesunate and sulfado
Externí odkaz:
https://doaj.org/article/89faea3afe42474799c01589fbf15bc4
Autor:
Abdelrahim O. Mohamed, Muzamil M. Abdel Hamid, Omer S. Mohamed, Nuha S. Elkando, Abdelmaroof Suliman, Mariam A. Adam, Fahad Awad Ali Elnour, Elfatih M. Malik
Publikováno v:
Malaria Journal, Vol 16, Iss 1, Pp 1-6 (2017)
Abstract Background Artemisinin-based combination therapy (ACT), together with other control measures, have reduced the burden of falciparum malaria in sub-Saharan countries, including Sudan. Sudan adopted ACT in 2004 with a remarkable reduction in m
Externí odkaz:
https://doaj.org/article/f2f5d839f29e441a9c123e8ee55232d3
Autor:
Maazza Hussien, Abdelrahim Osman Mohamed, Muzamil Mahdi Abdel Hamid, Elfatih M. Malik, Hanadi Abdelbagi, Mohammed H. Abdelraheem, Abdelmaroof Suliman, Amal Abdelrahim Osman Mohamed, Nuha S. Elkando
Publikováno v:
Mohamed, A O, Hussien, M, Mohamed, A, Suliman, A, Elkando, N S, Abdelbagi, H, Malik, E M, Abdelraheem, M H & Hamid, M M A 2020, ' Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan ', Malaria Journal, vol. 19, no. 1 . https://doi.org/10.1186/s12936-020-03165-0
Malaria Journal
Malaria Journal, Vol 19, Iss 1, Pp 1-7 (2020)
Malaria Journal
Malaria Journal, Vol 19, Iss 1, Pp 1-7 (2020)
Background Plasmodium falciparum malaria is a public health problem worldwide. Malaria treatment policy has faced periodic changes due to emergence of drug resistant parasites. In Sudan chloroquine has been replaced by artesunate and sulfadoxine/pyri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cad7f338587d51d34f59ede09223cba1
https://www.pure.ed.ac.uk/ws/files/137035151/Mohamed2020_Article_AssessmentOfPlasmodiumFalcipar.pdf
https://www.pure.ed.ac.uk/ws/files/137035151/Mohamed2020_Article_AssessmentOfPlasmodiumFalcipar.pdf
Autor:
Fahad Awad Ali Elnour, Abdelrahim Osman Mohamed, Omer S. Mohamed, Elfatih M. Malik, Muzamil Mahdi Abdel Hamid, Mariam A. Adam, Nuha S. Elkando, Abdelmaroof Suliman
Publikováno v:
Malaria Journal, Vol 16, Iss 1, Pp 1-6 (2017)
Malaria Journal
Malaria Journal
Background Artemisinin-based combination therapy (ACT), together with other control measures, have reduced the burden of falciparum malaria in sub-Saharan countries, including Sudan. Sudan adopted ACT in 2004 with a remarkable reduction in mortality